Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina

Annals of the New York Academy of Sciences

Volumn 1070, Issue , 2006, Pages 149-155

  Babai, Norbert ^a   Atlasz, Tamas ^a   Tamás, Andrea ^a   Reglodi, Dora ^a   Tóth, Gabor ^b   Kiss, Peter ^a   Gábriel, Robert ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Degeneration; MSG; PACAP; Plexiform layers; Retina; Ribbon synapses

Indexed keywords

GLUTAMATE SODIUM; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; EXCITOTOXICITY; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT; RETINA; RETINA DEGENERATION; ULTRASTRUCTURE;

EID: 33746442839     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1317.003     Document Type: Conference Paper

References (16)

1. SUCHER, N.J., S.A. LIPTON & E.B. DREYER. 1997. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 37: 3483-3493.
2. VIDAL-SANZ, M. et al. 2000. Death and neuroprotection of retinal ganglion cells after different types of injury. Neurotox. Res. 2: 215-227.
3. TAMÁS, A. et al. 2004. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodiumglutamate. Neurosci. Lett. 372: 110-113.
4. SEKI, T. et al. 2000. Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR. Ann. N. Y. Acad. Sci. 921: 366-369.
5. IZUMI, S. et al. 2000. Ultrastructural localization of PACAP immunoreactivity in the rat retina. Ann. N. Y. Acad. Sci. 921: 317-320.
6. SILVEIRA, M.S. et al. 2002. Pituitary adenylate cyclase activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase. J. Biol. Chem. 277: 16075-16080.
7. TUNCEL, N. et al. 1996. Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid. Ann. N. Y. Acad. Sci. 805: 489-498.
8. SEKI, T. et al. 2003. Pituitary adenylate cyclase activating polypeptide (PACAP) protects against ganglion cell death after cutting of optic nerve in the rat retina [abstract]. Regul. Pept. 115: 55.
9. SHOGE, K. et al. 1999. Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Res. 839: 66-73.
10. SAID, S.I. et al. 1998. Glutamate toxicity in the lung and neuronal cells: prevention or attenuation by VIP and PACAP. Ann. N. Y. Acad. Sci. 865: 226-237.
11. SHINTANI, N. et al. 2005. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul. Pept. 126: 123-128.
12. THORESON, W.B. & P. WITKOVSKY. 1999. Glutamate receptors and circuits in the vertebrate retina. Prog. Retin. Eye Res. 18: 765-810.
13. DOWLING, J.E. 1987. The Retina. An Approachable Part of the Brain. Belknap Press, Cambridge, MA.
14. KLEINSCHMIDT, J., C.L. ZUCKER & S. YAZULLA. 1986. Neurotoxic action of kainic acid in the isolated toad and goldfish retina: II. Mechanism of action. J. Comp. Neurol. 254: 196-208.
15. ROMANO, C., M.T. PRICE & J.W. OLNEY. 1995. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. J. Neurochem. 65: 59-67.
16. NILSSON, S.F. et al. 1994. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Exp. Eye Res. 58: 459-467.